Tetralogy of Fallot clinical trials at UCLA
2 in progress, 0 open to eligible people
ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent
Sorry, in progress, not accepting new patients
To demonstrate the safety and effectiveness of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) System in subjects with a dysfunctional right ventricular outflow tract/pulmonary valve (RVOT/PV) who are indicated for treatment of pulmonary regurgitation (PR). Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.
Los Angeles, California and other locations
Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study
Sorry, in progress, not accepting new patients
The purpose of this study is to further evaluate the safety and effectiveness of the Harmony™ TPV system. The Pivotal/CAS phases of the study have transitioned into a post-approval study to confirm the long-term functionality of transcatheter implantation of the Medtronic Harmony TPV.
Los Angeles, California and other locations
Our lead scientists for Tetralogy of Fallot research studies include Daniel Levi.
Last updated: